Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.PH)

ZIOP.PH on Philadelphia Stock Exchange

4.42USD
8 Dec 2017
Change (% chg)

$0.09 (+1.96%)
Prev Close
$4.34
Open
$4.42
Day's High
$4.46
Day's Low
$4.39
Volume
4,558
Avg. Vol
6,892
52-wk High
$7.87
52-wk Low
$3.91

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $628.90
Shares Outstanding(Mil.): 141.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

Nov 06 2017

BRIEF-Ziopharm Oncology reports Q2 loss per share $0.13

* Ziopharm Oncology reports second quarter 2017 financial results and provides update on recent activities

Jul 31 2017

BRIEF-Ziopharm Oncology announces initiation of stereotactic treatment cohort in phase 1 study of Ad-RTS-hIL-12 + veledimex in recurrent glioblastoma

* Ziopharm Oncology announces initiation of stereotactic treatment cohort in phase 1 study of Ad-RTS-hIL-12 + veledimex in recurrent glioblastoma

Jun 28 2017

Earnings vs. Estimates